secwatch.observer — SEC 8-K summary
======================================

Issuer:     Corbus Pharmaceuticals Holdings, Inc. (CRBP)
CIK:        0001595097
Form:       8-K
Filed at:   2023-05-19T23:59:59+00:00
Accession:  0000950170-23-023162
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Corbus Pharma annual meeting: all director nominees elected, auditor ratified, say-on-pay passes
--------------------------------------------------------------------------------

- Eight director nominees elected with 258k-281k votes for each; broker non-votes of 1.63M.
- Ratification of EisnerAmper as auditor passed: 1,806,011 for, 126,343 against, 15,139 abstain.
- Advisory vote on named executive officer compensation passed: 244,160 for, 60,487 against, 9,370 abstain.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1595097/000095017023023162/0000950170-23-023162-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1595097/000095017023023162/crbp-20230518.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-023162

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer